Eslicarbazepine For Epilepsy: What You Need To Know
Comprehensive guide to eslicarbazepine (Zebinix): uses, dosage, side effects, and management for focal epilepsy treatment.
Eslicarbazepine is an antiepileptic medication marketed as Zebinix in the UK and Aptiom elsewhere. It works by blocking voltage-gated sodium channels in the brain to stabilize electrical activity and prevent focal (partial) seizures, often used as add-on therapy when other treatments fail.
About eslicarbazepine tablets
Eslicarbazepine tablets, branded as Zebinix, belong to a group of medicines called antiepileptics. They are specifically indicated for adults with epilepsy who still experience seizures despite treatment with other antiepileptic drugs. Unlike carbamazepine, eslicarbazepine does not form an epoxide metabolite, potentially reducing some side effects associated with related drugs.
The tablets are available in strengths of 400 mg, 800 mg, 1000 mg, and 1200 mg, allowing for flexible dosing. They are taken once daily, which improves patient compliance compared to twice-daily regimens of similar drugs like oxcarbazepine.
Key facts
- Brand name: Zebinix (Aptiom in some countries)
- Dose: Usually starts at 400 mg once daily, increased to 800 mg, up to a maximum of 1200 mg daily
- Frequency: Once a day, preferably at the same time each day
- Duration: Long-term for ongoing seizure control; does not cure epilepsy
- Common side effects: Dizziness, somnolence, headache, nausea
- Prescription only: Yes, specialist initiation recommended
Clinical trials show eslicarbazepine significantly reduces seizure frequency, with higher efficacy at 800 mg and 1200 mg doses.
About epilepsy
Epilepsy is a chronic neurological disorder characterized by recurrent seizures due to abnormal electrical activity in the brain. Focal seizures, the primary target for eslicarbazepine, originate in one area of the brain and may spread, potentially becoming generalized tonic-clonic seizures. Up to 30% of patients have drug-resistant epilepsy, where seizures persist despite two or more antiepileptic drugs.
Eslicarbazepine is licensed for adjunctive therapy in adults with focal seizures with or without secondary generalization. It is not approved for primary generalized seizures or use as monotherapy.
How eslicarbazepine works
Eslicarbazepine acetate is a prodrug rapidly metabolized to eslicarbazepine, the active form. It acts as a high-affinity antagonist of voltage-gated sodium channels (VGSCs), particularly those in the inactivated state, selectively inhibiting rapidly firing neurons responsible for seizures.
This mechanism is similar to carbamazepine and oxcarbazepine but with greater efficacy in animal models and no epoxide formation, reducing toxicity risks. Its half-life of 20-24 hours supports once-daily dosing, enhancing adherence.
How and when to take eslicarbazepine
Take eslicarbazepine once daily, with or without food, at the same time each day to maintain steady blood levels. Swallow tablets whole with water; do not crush or chew.
- Starting dose: 400 mg once daily for 1-2 weeks
- Maintenance dose: Increase to 800 mg daily; may go to 1200 mg if needed and tolerated
- Missed dose: Take as soon as remembered unless close to next dose; do not double up
- Overdose: Seek immediate medical help; symptoms include dizziness, somnolence, tremors
Dose adjustments may be needed for liver/kidney impairment or elderly patients.
Dosage
| Patient Group | Starting Dose | Target Dose | Maximum Dose |
|---|---|---|---|
| Adults (18-74 years) | 400 mg/day | 800 mg/day | 1200 mg/day |
| Elderly (>75 years) | 400 mg/day | 800 mg/day | 800 mg/day (reduce if needed) |
| Mild liver impairment | 400 mg/day | 800 mg/day | 1200 mg/day |
| Moderate liver impairment | Avoid or 400 mg/day max | N/A | 800 mg/day |
| Severe liver impairment | Contraindicated | N/A | N/A |
Titrate slowly over 2 weeks to minimize side effects. Efficacy increases with dose: 22% response at 400 mg, 66% at 800 mg, 92% at 1200 mg (50% seizure reduction).
Side effects of eslicarbazepine
Side effects are usually mild to moderate and improve over time. Common ones affect over 1 in 10 people.
- Very common (>1/10): Dizziness (RR 2.13), somnolence (RR 1.71), headache
- Common (1/100-1/10): Nausea, vomiting, fatigue, diplopia (RR 4.14), blurred vision, tremor
- Serious (seek help): Severe rash, suicidal thoughts, hyponatremia (low sodium), heart rhythm changes (PR prolongation)
In RCTs, 8-19.6% discontinued due to adverse events vs. 3.9-8.5% on placebo. Higher doses increase risk.
Pregnancy and breastfeeding
Eslicarbazepine may harm the unborn baby; use only if benefits outweigh risks. Effective contraception is essential during treatment and for 1 month after stopping, as it can reduce hormonal contraceptive efficacy.
Limited data on breastfeeding; avoid or monitor infant for drowsiness/sedation. Consult specialist.
Cautions of eslicarbazepine
- Heart block (2nd/3rd degree contraindicated)
- Hyponatremia risk; monitor sodium levels
- Liver/kidney disease
- History of hypersensitivity to carbamazepine/oxcarbazepine
- Caution with drugs prolonging PR interval (e.g., beta-blockers)
Monitor for skin reactions, mood changes, or infection.
Interactions
Eslicarbazepine induces CYP3A4 and inhibits CYP2C19, affecting many drugs.
- Contraceptives: Use non-hormonal methods
- Other AEDs: Carbamazepine (increase dose), lamotrigine (monitor)
- Simvastatin/rosuvastatin: Dose reduction needed
- Warfarin: Monitor INR
Full list via specialist or BNF.
Other medicines, food and drink, alcohol
Discuss all medications with your doctor. Avoid excessive alcohol, as it increases dizziness risk. No major food interactions.
Common questions about eslicarbazepine
How long does eslicarbazepine take to work?
Seizure reduction may start within 1-2 weeks, but full effect in 4-12 weeks. Continue as prescribed.
Can you stop taking eslicarbazepine suddenly?
No; taper gradually over weeks to avoid rebound seizures. Consult doctor.
Does eslicarbazepine cause weight gain?
Not typically; some report appetite changes.
Can you drive on eslicarbazepine?
Only if seizure-free for 12 months and no side effects impairing driving. Follow DVLA rules.
Is eslicarbazepine suitable for children?
Licensed for adults; pediatric data limited, though FDA approves from age 4 in some regions.
Clinical evidence
Cochrane review of 5 RCTs (1799 adults) showed 71% greater chance of ≥50% seizure reduction (RR 1.71) and 2.9x seizure freedom vs. placebo, especially at 800-1200 mg. Responders: 54% at 1200 mg vs. 28% placebo.
References
- Eslicarbazepine Acetate Reduced Seizures in Adults With Treatment-Resistant Focal Epilepsy — Neurology Advisor (Cochrane Review). 2017-approx. https://www.neurologyadvisor.com/news/eslicarbazepine-acetate-reduced-seizures-in-adults-with-treatment-resistant-focal-epilepsy/
- Eslicarbazepine drug information — Cambridge University Hospitals NHS. Recent. https://www.cuh.nhs.uk/patient-information/eslicarbazepine-drug-information/
- Role of eslicarbazepine in the treatment of epilepsy in adult patients — PMC/NCBI (Peer-reviewed). 2010-04-22. https://pmc.ncbi.nlm.nih.gov/articles/PMC2857610/
- Eslicarbazepine (oral route) – Side effects & dosage — Mayo Clinic. Recent. https://www.mayoclinic.org/drugs-supplements/eslicarbazepine-oral-route/description/drg-20084844
- Eslicarbazepine Acetate (Aptiom) — Epilepsy Foundation. Recent. https://www.epilepsy.com/tools-resources/seizure-medication-list/eslicarbazepine-acetate
Similar Articles
Read full bio of medha deb
